ME/CFS AUSTRALIA (SA) INC
Registered Charity 698
PO Box 28,
South Australia 5007
North Terrace House,
19 North Terrace,
Hackney, SA, 5069
1300 128 339
ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
Fibromyalgia Sleep Study
Friday 24 July 2015
Local doctor fighting fibromyalgia
SouthCoast Health’s Dr. Victor Rosenfeld’s recently published a sleep study that simplifies the diagnosis for fibromyalgia, could improve pain and stress as well as address the lack of sleep in patients affected by the syndrome.
Rosenfeld, head of the neurology department and medical director at SouthCoast Health, had his study published in the Journal of Clinical Neurophysiology’s April 2015 edition.
Rosenfeld tested nearly 500 patients with and without fibromyalgia in a sleep lab. While the patients slept, Rosenfeld observed their brain waves through a process known as quantitative EEG and utilized the process to monitor the patients’ alpha waves.
The brain creates alpha waves while it is awake, Rosenfeld said. He detected alpha waves in the vast majority of fibromyalgia patients but did not in those without fibromyalgia.
“Even though people with fibromyalgia are technically asleep, their brain waves look more like they’re awake,” Rosenfeld said. “In essence, people with fibromyalgia are pulling an all-nighter every single night.”
Such a finding explains why most fibromyalgia patients often report feeling tired, fatigued, achy and unfocused, he said.
Fibromyalgia is the most common widespread pain syndrome in the world, and it affects between 2 and 6 percent of the population. Women are eight times more likely to develop fibromyalgia than men, according to Rosenfeld. Fibromyalgia’s cost to the U.S. economy is estimated at $10 billion annually.
Rosenfeld’s study has the potential to reduce that figure by eliminating unnecessary testing for the condition.
There is no specific test for fibromyalgia, so it’s not uncommon for patients to visit with cardiologists, gastroenterologists and rheumatologists before they get a proper diagnosis.
“Fibromyalgia patients have a bewildering array of symptoms, so they’ll typically go see many types of doctors,” Rosenfeld said. “Now we can easily and quickly identify the condition and save millions of dollars potentially from wasted time and diagnoses.”
The sleep study is widely available. Its easy accessibility allows patients to receive a quick diagnosis and to get started on a treatment plan that addresses their symptoms.
Since there’s no known cure for fibromyalgia, reducing pain levels in patients is important, Rosenfeld said. Exercise, especially aquatic therapies, as well as improving one’s diet helps reduce symptoms.
Above all, improving patients’ sleep is at the top of the agenda.
“Focusing on the patients’ sleep and helping their sleep is probably one of the most important things that we can do,” Rosenfeld said.
Rosenfeld published the study, which is titled as “Polysomnography With Quantitative EEG in Patients With and Without Fibromyalgia,” alongside co-authors Dana N. Rutledge, a nursing professor at California State-Fullerton, and Dr. John M. Stern, director of the Epilepsy Clinical Program at UCLA’s David Geffen School of Medicine.
Rosenfeld is board certified in neurology and sleep medicine and has been published in several medical publications on topics such as sleep medicine, Huntington’s disease and sleep apnea.
The above originally appeared here.
blog comments powered by Disqus